AR002001A1 - Solucion para administracion intravenosa de lubeluzol, procedimiento para su preparacion, una jeringa previamente llenada, un paquete para infusion parael tratamiento agudo del infarto y el uso de sustancias acidas o basicas en una solucion. - Google Patents
Solucion para administracion intravenosa de lubeluzol, procedimiento para su preparacion, una jeringa previamente llenada, un paquete para infusion parael tratamiento agudo del infarto y el uso de sustancias acidas o basicas en una solucion.Info
- Publication number
- AR002001A1 AR002001A1 ARP950100296A AR10029695A AR002001A1 AR 002001 A1 AR002001 A1 AR 002001A1 AR P950100296 A ARP950100296 A AR P950100296A AR 10029695 A AR10029695 A AR 10029695A AR 002001 A1 AR002001 A1 AR 002001A1
- Authority
- AR
- Argentina
- Prior art keywords
- solution
- acidic
- basic substances
- infarction
- procedure
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Una solución para administración intravenosa que contiene lubeluzol o una sal de adición farmacéuticamente aceptable del mismo, un agente isotonizante,agua y sustancias ácidas o básicas para ajustar el pH de la solución en el intervalo de 2,5a 3,6, procedimiento para prepararla, una jeringapreviamente llenada con una solución, un paquete para infusión para el tratamiento agudo del infarto y el uso de sustancias ácidas o básicas en unasolución para evitar la absorción de lubeluzol o sus sales a las paredes del equipo de administración.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP94203422 | 1994-11-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR002001A1 true AR002001A1 (es) | 1998-01-07 |
Family
ID=8217408
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP950100296A AR002001A1 (es) | 1994-11-24 | 1995-11-23 | Solucion para administracion intravenosa de lubeluzol, procedimiento para su preparacion, una jeringa previamente llenada, un paquete para infusion parael tratamiento agudo del infarto y el uso de sustancias acidas o basicas en una solucion. |
Country Status (19)
Country | Link |
---|---|
US (1) | US5744484A (es) |
EP (1) | EP0794777A1 (es) |
JP (1) | JPH10509712A (es) |
CN (1) | CN1166787A (es) |
AR (1) | AR002001A1 (es) |
AU (1) | AU693969B2 (es) |
BR (1) | BR9509821A (es) |
CA (1) | CA2205606A1 (es) |
CZ (1) | CZ155897A3 (es) |
FI (1) | FI972204A0 (es) |
HU (1) | HUT77390A (es) |
IL (1) | IL116102A (es) |
MX (1) | MX9703839A (es) |
NO (1) | NO972303D0 (es) |
PL (1) | PL320296A1 (es) |
SK (1) | SK65197A3 (es) |
TR (1) | TR199501482A1 (es) |
WO (1) | WO1996015790A1 (es) |
ZA (1) | ZA959995B (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SA96170106A (ar) * | 1995-07-06 | 2005-12-03 | أسترا أكتيبولاج | مشتقات حامض أميني جديدة |
AU7298196A (en) * | 1995-10-25 | 1997-05-15 | Janssen Pharmaceutica N.V. | Infusions of neuroprotectants and perfluorochemicals |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1260474A (en) * | 1984-12-03 | 1989-09-26 | Raymond A. Stokbroekx | Benzoxazol- and benzothiazolamine derivatives |
US5010198A (en) * | 1984-12-03 | 1991-04-23 | Janssen Pharmaceutica N.V. | Intermediates for the synthesis of benzoxazol- and benzothiazolamine derivatives, useful as anti-anoxic agents |
ZW1992A1 (en) * | 1991-02-25 | 1993-09-22 | Janssen Pharmaceutica Nv | 4-/(2-benzotiazolyl)methylamino/-b-/(3,4-difluorephenoxy)methyl/-1-piperidine ethanol |
-
1995
- 1995-11-16 PL PL95320296A patent/PL320296A1/xx unknown
- 1995-11-16 WO PCT/EP1995/004520 patent/WO1996015790A1/en not_active Application Discontinuation
- 1995-11-16 MX MX9703839A patent/MX9703839A/es unknown
- 1995-11-16 CA CA002205606A patent/CA2205606A1/en not_active Abandoned
- 1995-11-16 AU AU41729/96A patent/AU693969B2/en not_active Ceased
- 1995-11-16 CN CN95196419A patent/CN1166787A/zh active Pending
- 1995-11-16 BR BR9509821A patent/BR9509821A/pt not_active Application Discontinuation
- 1995-11-16 CZ CZ971558A patent/CZ155897A3/cs unknown
- 1995-11-16 EP EP95940191A patent/EP0794777A1/en not_active Withdrawn
- 1995-11-16 US US08/817,740 patent/US5744484A/en not_active Expired - Lifetime
- 1995-11-16 SK SK651-97A patent/SK65197A3/sk unknown
- 1995-11-16 JP JP8516550A patent/JPH10509712A/ja active Pending
- 1995-11-16 HU HU9702128A patent/HUT77390A/hu unknown
- 1995-11-23 ZA ZA959995A patent/ZA959995B/xx unknown
- 1995-11-23 AR ARP950100296A patent/AR002001A1/es unknown
- 1995-11-23 IL IL11610295A patent/IL116102A/xx active IP Right Grant
- 1995-11-24 TR TR95/01482A patent/TR199501482A1/xx unknown
-
1997
- 1997-05-21 NO NO972303A patent/NO972303D0/no not_active Application Discontinuation
- 1997-05-23 FI FI972204A patent/FI972204A0/fi unknown
Also Published As
Publication number | Publication date |
---|---|
SK65197A3 (en) | 1997-12-10 |
IL116102A0 (en) | 1996-01-31 |
CZ155897A3 (en) | 1997-10-15 |
WO1996015790A1 (en) | 1996-05-30 |
FI972204A (fi) | 1997-05-23 |
AU693969B2 (en) | 1998-07-09 |
US5744484A (en) | 1998-04-28 |
IL116102A (en) | 2000-02-29 |
NO972303L (no) | 1997-05-21 |
BR9509821A (pt) | 1997-10-21 |
EP0794777A1 (en) | 1997-09-17 |
CA2205606A1 (en) | 1996-05-30 |
ZA959995B (en) | 1997-05-23 |
TR199501482A1 (tr) | 1996-10-21 |
HUT77390A (hu) | 1998-04-28 |
MX9703839A (es) | 1997-08-30 |
FI972204A0 (fi) | 1997-05-23 |
AU4172996A (en) | 1996-06-17 |
JPH10509712A (ja) | 1998-09-22 |
CN1166787A (zh) | 1997-12-03 |
NO972303D0 (no) | 1997-05-21 |
PL320296A1 (en) | 1997-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9203556A (es) | Una forma de dosificacion para administrar los farmacos beneficos pseudoefedrina y bromofeniramina. | |
IT1214872B (it) | Sacca contenente due o piu'sostanze per infusione ad uso medicale, poste in scomparti separati, comprendente mezzi atti a consentire la miscelazione di tali sostanze solo al momento dell'uso. | |
IL80149A (en) | Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases | |
ES2077530B1 (es) | Procedimiento para la preparacion de productos farmaceuticos para curar enfermedades tumorales. | |
SE8402560D0 (sv) | Farmaceutisk komposition | |
AR033688A1 (es) | Composicion parenteral reconstituible | |
ES2074124T5 (es) | Composicion en forma de una espuma que contiene acido 5-aminosalicilico para administracion intra-rectal. | |
AR012995A1 (es) | Uso de un sensibilizador a insulina y de un agente antihiperglucemico para la preparacion de medicamentos y composiciones farmaceuticas que contienedichos compuestos. | |
ES2171469T3 (es) | Composicion administrada por via nasal y preparacion que la contiene. | |
IT8667641A0 (it) | Dispositivo erogatore per somministrare un agente terapeutico all ambiente d uso provvisto di mezzi per incrementare l erogazione didetto agente | |
ES2074490T3 (es) | Procedimiento para la elaboracion de un preparado de inmunoglobulina g tolerable por via intravenosa. | |
AR019053A1 (es) | Uso de 2'2'-difluoronucleosidos para la preparacion de un medicamento y composicion farmaceutica y producto farmaceutico que los contienen | |
ES2135342B1 (es) | Uso del raloxifeno o una sal o salvato del mismo en la preparacion de un medicamento para prevenir el cancer de mama. | |
MX9205568A (es) | Composicion farmaceutica que contiene cantidades de 5-amino-1beta-d-ribofuranosil-imidazol-4-carboxamida. | |
ES277844Y (es) | Una disposicion de punta de dosificacion para administrar una dosis de medicamento, alimentos, vitaminas o similares, a un paciente | |
MC2025A1 (fr) | Medicament contenant de l'azelastine et capable de liberer celle-ci de facon controlee | |
SE8102456L (sv) | Farmaceutisk komposition for oral administering och innehallande cytidindifosfokolin | |
ES2142430T3 (es) | Compuestos farmaceuticos en forma de gel conteniendo sales de sulfato de condroitina apropiadas para administracion oral. | |
ATE38151T1 (de) | Bestaendige 5-adenosyl-l-methionin-salze enthaltende, pharmazeutische zusammensetzungen fuer orale anwendung. | |
AR002001A1 (es) | Solucion para administracion intravenosa de lubeluzol, procedimiento para su preparacion, una jeringa previamente llenada, un paquete para infusion parael tratamiento agudo del infarto y el uso de sustancias acidas o basicas en una solucion. | |
AR011437A1 (es) | Composicion farmaceutica para el tratamiento de la migrana y el uso de la misma en la preparacion de un medicamento. | |
ATE212555T1 (de) | Impfstoffverabreichungssystem | |
ES2078256T3 (es) | Formula farmaceutica para uso topico que contiene diclofenaco sodico. | |
FI920428A0 (fi) | Ett podofyllotoxinpreparat som innehaoller triglyserider. | |
AR012638A1 (es) | Uso de pregnan-3-ol-20-onas para la manufactura de un medicamento util para proveer una terapia progestacional |